Language
English
Publication Date
9-3-2025
Journal
Antimicrobial Agents and Chemotherapy
DOI
10.1128/aac.00780-25
PMID
40801833
PMCID
PMC12406684
PubMedCentral® Posted Date
8-13-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Although the article by J Càmara, I Grau, A González-Díaz, N Santos, et al. (Antimicrob Agents Chemother 69:e00237-25, 2025, https://doi.org/10.1128/aac.00237-25) suggests that ceftriaxone is greatly superior to amoxicillin in treating pneumonia due to pneumococci with an MIC > 2 mg/L, much of the difference in efficacy of the two drugs may have been due to dosage, route, and times of administration of the amoxicillin.
Keywords
Ceftriaxone, Streptococcus pneumoniae, Amoxicillin, Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Pneumonia, Pneumococcal, Streptococcus pneumoniae, amoxicillin, ceftriaxone
Published Open-Access
yes
Recommended Citation
Daniel M Musher, "Amoxicillin vs. Ceftriaxone To Treat Pneumonia Caused by Amoxicillin-Non-Susceptible Streptococcus pneumoniae" (2025). Faculty and Staff Publications. 4683.
https://digitalcommons.library.tmc.edu/baylor_docs/4683